C

China NT Pharma Group Company Ltd
HKEX:1011

Watchlist Manager
China NT Pharma Group Company Ltd
HKEX:1011
Watchlist
Price: 0.93 HKD 10.71% Market Closed
Market Cap: 627.1m HKD

Intrinsic Value

The intrinsic value of one China NT Pharma Group Company Ltd stock under the Base Case scenario is 0.32 HKD. Compared to the current market price of 0.93 HKD, China NT Pharma Group Company Ltd is Overvalued by 66%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
0.32 HKD
Overvaluation 66%
Intrinsic Value
Price
C
Worst Case
Base Case
Best Case

Valuation History
China NT Pharma Group Company Ltd

What is Valuation History?
Ask AI Assistant
What other research platforms think about China NT Pharma Group Company Ltd?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is China NT Pharma Group Company Ltd valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for China NT Pharma Group Company Ltd.

Explain Valuation
Compare China NT Pharma Group Company Ltd to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about China NT Pharma Group Company Ltd?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
China NT Pharma Group Company Ltd

Current Assets 28.2m
Cash & Short-Term Investments 4.6m
Receivables 8.7m
Other Current Assets 14.9m
Non-Current Assets 316.2m
Long-Term Investments 315.1m
PP&E 1.1m
Other Non-Current Assets 48k
Current Liabilities 620.9m
Accounts Payable 178.5m
Accrued Liabilities 126.7m
Other Current Liabilities 315.7m
Non-Current Liabilities 375k
Long-Term Debt 375k
Efficiency

Free Cash Flow Analysis
China NT Pharma Group Company Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
China NT Pharma Group Company Ltd

Revenue
18.7m CNY
Cost of Revenue
-9.1m CNY
Gross Profit
9.6m CNY
Operating Expenses
-34.8m CNY
Operating Income
-25.3m CNY
Other Expenses
-45.7m CNY
Net Income
-70.9m CNY
Fundamental Scores

Profitability Score
Profitability Due Diligence

China NT Pharma Group Company Ltd's profitability score is 38/100. The higher the profitability score, the more profitable the company is.

Exceptional 3Y Average ROE
Strong 3Y Average Gross Margin
Positive ROE
Exceptional Gross Margin
38/100
Profitability
Score

China NT Pharma Group Company Ltd's profitability score is 38/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

China NT Pharma Group Company Ltd's solvency score is 32/100. The higher the solvency score, the more solvent the company is.

Negative Net Debt
Low D/E
Long-Term Solvency
Short-Term Solvency
32/100
Solvency
Score

China NT Pharma Group Company Ltd's solvency score is 32/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
China NT Pharma Group Company Ltd

There are no price targets for China NT Pharma Group Company Ltd.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for China NT Pharma Group Company Ltd is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one China NT Pharma Group Company Ltd stock?

The intrinsic value of one China NT Pharma Group Company Ltd stock under the Base Case scenario is 0.32 HKD.

Is China NT Pharma Group Company Ltd stock undervalued or overvalued?

Compared to the current market price of 0.93 HKD, China NT Pharma Group Company Ltd is Overvalued by 66%.

Back to Top